We are live on ! Find out more
JGGDR

JGP Global Gestao de Recursos Portfolio holdings

AUM $45.3M
1-Year Est. Return 42.75%
This Fund
S&P 500
This Quarter Est. Return
-5.95%
1 Year Est. Return
+42.75%
3 Year Est. Return
+205.51%
5 Year Est. Return
+441.7%
10 Year Est. Return
+707.39%
AUM
$78.8M
AUM Growth
-$76.8M
Cap. Flow
-$71.7M
Cap. Flow %
-91.02%
Top 10 Hldgs %
87.97%
Holding
62
New
1
Increased
5
Reduced
24
Closed
21

Top Buys

Rank Stock Value
1
STNE icon
StoneCo
STNE
+$14.1M
2
SPGI icon
S&P Global
SPGI
+$858K
3
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$195K
4
AEM icon
Agnico Eagle Mines
AEM
+$178K
5
XOM icon
ExxonMobil
XOM
+$64.4K

Top Sells

Rank Stock Value
1
XP icon
XP
XP
+$29.9M
2
NGD
New Gold Inc
NGD
+$7.03M
3
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$3.99M
4
NU icon
Nu Holdings
NU
+$2.69M
5
INTR icon
Inter&Co
INTR
+$1.31M

Sector Composition

Rank Sector Weight
1 Technology 30.81%
2 Financials 22.95%
3 Healthcare 19.21%
4 Materials 1.15%
5 Energy 0.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NGD
26
DELISTED
New Gold Inc
NGD
$241K 0.31%
123,527
-3,700,000
-97% -$7.03M
RYTM icon
27
Rhythm Pharmaceuticals
RYTM
$7.96B
$239K 0.3%
5,814
-100,000
-95% -$3.99M
NVO
28
Novo Nordisk
NVO
$209B
$235K 0.3%
1,649
-19
-1% -$2.52K
MOH icon
29
Molina Healthcare
MOH
$10.3B
$229K 0.29%
769
-9
-1% -$3.06K
CI icon
30
Cigna
CI
$74.6B
$210K 0.27%
636
-7
-1% -$2.41K
ROIV icon
31
Roivant Sciences
ROIV
$26.2B
$106K 0.13%
10,036
– –
BCRX icon
32
BioCryst Pharmaceuticals
BCRX
$2.4B
$67.1K 0.09%
10,865
– –
ABCL icon
33
AbCellera Biologics
ABCL
$2.12B
$52.6K 0.07%
17,779
– –
KOD icon
34
Kodiak Sciences
KOD
$2.84B
$35.1K 0.04%
14,957
– –
CERS icon
35
Cerus
CERS
$474M
$25.6K 0.03%
14,539
– –
OIBR.C
36
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
$1.5K ﹤0.01%
575,000
– –
AMZN icon
37
Amazon
AMZN
$2.96T
– –
-1,529
Closed -$276K
BDX icon
38
Becton Dickinson
BDX
$48.2B
– –
-822
Closed -$203K
DBVT
39
DBV Technologies
DBVT
$847M
– –
-1,191
Closed -$8.92K
GDX icon
40
VanEck Gold Miners ETF
GDX
$27.4B
– –
-21,093
Closed -$667K
GGAL icon
41
Galicia Financial Group
GGAL
$7.42B
– –
-10,000
Closed -$254K
IMCR icon
42
Immunocore
IMCR
$1.73B
– –
-4,253
Closed -$276K
INTR icon
43
Inter&Co
INTR
$2.33B
– –
-229,172
Closed -$1.31M
ITUB icon
44
Itaú Unibanco
ITUB
$87.5B
– –
-19,808
Closed -$121K
J icon
45
Jacobs Solutions
J
$17B
– –
-4,372
Closed -$556K
KYMR icon
46
Kymera Therapeutics
KYMR
$8.94B
– –
-5,183
Closed -$208K
SHEL icon
47
Shell
SHEL
$245B
– –
-3,975
Closed -$266K
STNE icon
48
PUT
StoneCo
STNE
$2.58B
– –
-6,500
Closed -$81.3K
STT icon
49
State Street
STT
$50.7B
– –
-3,723
Closed -$288K
TXT icon
50
PUT
Textron
TXT
$15.4B
– –
-2,000
Closed -$25K
1
2
3

Similar funds

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
RRC
Range Rock Capital Wellesley, Massachusetts $46.7M AUM

JGP Global Gestao de Recursos's Q2 2024 Portfolio in Review

As of Q2 2024, JGP Global Gestao de Recursos held 62 positions worth $78.8M, down 49% from $156M the previous quarter. Its ten largest holdings account for 88% of the portfolio.

JGP Global Gestao de Recursos withdrew a net $71.7M in Q2 2024, closing 21 positions and reducing 24 holdings. Its most notable exit was XP, an estimated $29.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

Against the trend, JGP Global Gestao de Recursos opened a new position in Alnylam Pharmaceuticals worth $300K.

  • JGP Global Gestao de Recursos's largest Q2 2024 buy was Alnylam Pharmaceuticals: 1,233 shares worth $300K.
  • JGP Global Gestao de Recursos added most to StoneCo in Q2 2024, an estimated $14.1M increase.
  • JGP Global Gestao de Recursos's biggest Q2 2024 reduction was New Gold Inc, cutting an estimated $7.03M.
  • JGP Global Gestao de Recursos fully exited XP in Q2 2024, selling an estimated $29.9M.
  • JGP Global Gestao de Recursos's ten largest holdings make up 88% of its $78.8M portfolio in Q2 2024.
  • JGP Global Gestao de Recursos opened 1 new position and closed 21 in Q2 2024.
  • JGP Global Gestao de Recursos's portfolio value fell 49% quarter-over-quarter to $78.8M.

Based on JGP Global Gestao de Recursos's 13F filing for Q2 2024, filed 2 Aug 2024.